To sum up, this systematic review provides a comprehensive summary of the current state of knowledge on the potential role of the guanylyl cyclase-c receptor (GC-C) and its endogenous ligands, Guanylin and Uroguanylin, in the development and progression of colorectal cancer (CRC). Here, GUCY2C is linked to colorectal carcinoma.